New scan could spot lung cancer return sooner
NCT ID NCT02821936
First seen Jan 04, 2026 · Last updated Jun 19, 2026 · Updated 26 times
Summary
This study looked at whether a special type of PET scan, called parametric imaging, can better predict if lung cancer will come back within a year after treatment. Forty patients with non-small cell lung cancer who were getting radiation and chemotherapy had two of these scans. The goal was to see if this method is more accurate than a standard PET scan for spotting cancer recurrence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
APHM
Marseille, 13000, France
-
Centre Henri Becquerel
Rouen, 76000, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a more accurate way to predict lung cancer recurrence, helping doctors decide if treatment adjustments are needed.
What could go wrong
This is a small, early-stage study with only 40 participants. It is not testing a new treatment, only a new imaging method, so it may not change patient care directly.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.